Editas Medicine (EDIT) Interest Expenses (2025)

Editas Medicine (EDIT) reported Interest Expenses of $2.4 million for Q3 2025, up 18.76% quarter-over-quarter from $2.0 million in Q2 2025.

Editas Medicine (EDIT) Interest Expenses (2025) Analysis & Trends

Editas Medicine (EDIT) has 1 years of Interest Expenses data on file, last reported at $2.4 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-5.50 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-332,000.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	61,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-2,753.00
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-5.58 Mn
10	Editas Medicine	262.77 Mn	262.77 Mn	-	-

Download Data